13F-HR filed by Keel Point, LLC
Keel Point, LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 514 holding rows worth $1,693,400,124.
- Accession
- 0001386935-26-000003
- Filer
- CIK 1386935
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 520 entries on the cover page, a total value of $1,693,400,124 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,693,400,124 with VALUE read as dollars as filed, 13F file number 028-12097. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DHI GROUP INC | 23331S100 | COM | 43,228 | $160,376 | dollars as filed | |
| HALEON PLC SPON ADS | 405552100 | ADR | 16,985 | $158,468 | dollars as filed | |
| BELLRING BRANDS INC COMMON STOCK | 07831C103 | Stock | 11,016 | $142,547 | dollars as filed | |
| AMC ENTMT HLDGS INC | 00165C302 | CL A NEW | 67,434 | $128,125 | dollars as filed | |
| ARCHER AVIATION INC | 03945R102 | COM CL A | 26,589 | $125,766 | dollars as filed | |
| NEOVOLTA INC | 640655106 | CMN | 32,355 | $101,918 | dollars as filed | |
| VERRA MOBILITY CORP CL A COM STK | 92511U102 | Stock | 23,185 | $98,536 | dollars as filed | |
| TERRA INNOVATUM GLOBAL NV | N85083108 | ORD SHS | 17,720 | $87,182 | dollars as filed | |
| MEDICAL PROPERTIES TRUST INC COM | 58463J304 | REIT | 15,524 | $71,721 | dollars as filed | |
| ICL GROUP LTD SHS | M53213100 | Stock | 10,608 | $52,828 | dollars as filed | |
| VENU HLDG CORP | 92333E104 | COM | 18,656 | $42,349 | dollars as filed | |
| SERINA THERAPEUTICS INC | 81751A108 | COM SHS | 21,508 | $41,726 | dollars as filed | |
| FLYEXCLUSIVE INC | 343928107 | COMMON STOCK | 19,102 | $38,204 | dollars as filed | |
| GT BIOPHARMA INC | 36254L308 | COM | 20,768 | $10,170 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001386935-26-000003 | this filing | 2026-08-14 | acceptance time not in the bulk data set |